Takeda Pharmaceuticals Czech Republic s.r.o. operates as the local subsidiary of Takeda Pharmaceutical Company Limited, a global biopharmaceutical group. The company focuses on commercialization, market access and medical support for prescription medicines across selected therapeutic areas including gastroenterology, rare diseases, oncology, neuroscience and plasma-derived therapies. Operations are centered on the Czech pharmaceutical market, integrated into Takeda's global research, manufacturing and supply network. Key assets include access to Takeda's global product portfolio, strong regulatory and medical expertise and established relationships with healthcare stakeholders. Strategic focus emphasizes patient-centric innovation, sustainable access to therapies and long-term value creation in specialized therapeutic areas.
Headquarters
Skretova 490/12
Prague; The City of Prague;
Postal Code: 12000
Contact Details: Purchase the Takeda Pharmaceuticals Czech Republic S.R.O. report to view the information.
Website: https://www.takeda.com/cz-cz/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service